These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 38106451)

  • 1. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.
    Zhang J; Chen B; Gan C; Sun H; Zhang J; Feng L
    Int J Nanomedicine; 2023; 18():7605-7635. PubMed ID: 38106451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery strategies and potential targets for siRNA in major cancer types.
    Lee SJ; Kim MJ; Kwon IC; Roberts TM
    Adv Drug Deliv Rev; 2016 Sep; 104():2-15. PubMed ID: 27259398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticulate RNA delivery systems in cancer.
    Sharma A; Jha NK; Dahiya K; Singh VK; Chaurasiya K; Jha AN; Jha SK; Mishra PC; Dholpuria S; Astya R; Nand P; Kumar A; Ruokolainen J; Kesari KK
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1271. PubMed ID: 32729987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology.
    Ebrahimi N; Manavi MS; Nazari A; Momayezi A; Faghihkhorasani F; Rasool Riyadh Abdulwahid AH; Rezaei-Tazangi F; Kavei M; Rezaei R; Mobarak H; Aref AR; Fang W
    Environ Res; 2023 Dec; 239(Pt 2):117263. PubMed ID: 37797672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
    Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
    Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.
    Liu F; Wang C; Gao Y; Li X; Tian F; Zhang Y; Fu M; Li P; Wang Y; Wang F
    Mol Diagn Ther; 2018 Oct; 22(5):551-569. PubMed ID: 29926308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Yadav DN; Ali MS; Thanekar AM; Pogu SV; Rengan AK
    Mol Pharm; 2022 Dec; 19(12):4506-4526. PubMed ID: 36409653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
    Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
    Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.
    Mahmoodi Chalbatani G; Dana H; Gharagouzloo E; Grijalvo S; Eritja R; Logsdon CD; Memari F; Miri SR; Rad MR; Marmari V
    Int J Nanomedicine; 2019; 14():3111-3128. PubMed ID: 31118626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
    Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
    Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic siRNA: principles, challenges, and strategies.
    Gavrilov K; Saltzman WM
    Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
    Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
    J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
    Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
    Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing highly active siRNAs for therapeutic applications.
    Walton SP; Wu M; Gredell JA; Chan C
    FEBS J; 2010 Dec; 277(23):4806-13. PubMed ID: 21078115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.